Oral manifestation in inflammatory bowel disease: A review

World Journal of Gastroenterology

Volumn 19, Issue 46, 2013, Pages 8571-8579

  Lankarani, Kamran B ^a   Sivandzadeh, Gholam Reza ^b   Hassanpour, Shima ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aphthous stomatitis; Cobblestoning; Crohn's disease; Extra intestinal manifestations; Inflammatory bowel disease; Mucogingivitis; Oral manifestation; Pyostomatitis vegetans; Ulcerative colitis

Indexed keywords

ADALIMUMAB; ANALGESIC AGENT; ANTIBIOTIC AGENT; AZATHIOPRINE; BECLOMETASONE; CLOFAZIMINE; CYCLOSPORIN A; DAPSONE; DEXAMETHASONE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LIDOCAINE; MESALAZINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; SULFAMETHOXYPYRIDAZINE; TACROLIMUS; THALIDOMIDE; TRIAMCINOLONE;

ANGULAR CHEILITIS; APHTHOUS STOMATITIS; COBBLESTONING; CROHN DISEASE; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; GINGIVITIS; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MOUTH ABSCESS; MOUTH DISEASE; MOUTH LESION; MOUTH ULCER; OROFACIAL GRANULOMATOSIS; PREVALENCE; PYOSTOMATITIS VEGETANS; REVIEW; ULCERATIVE COLITIS;

APHTHOUS STOMATITIS; COBBLESTONING; CROHN'S DISEASE; EXTRA-INTESTINAL MANIFESTATIONS; INFLAMMATORY BOWEL DISEASE; MUCOGINGIVITIS; ORAL MANIFESTATION; PYOSTOMATITIS VEGETANS; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MOUTH DISEASES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84890340717     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i46.8571     Document Type: Review

References (107)

1. Lourenço SV, Hussein TP, Bologna SB, Sipahi AM, Nico MM. Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases. J Eur Acad Dermatol Venereol 2010; 24: 204-207 [PMID: 19552719 DOI: 10.1111/j.468-3083.2009.03304.x]
2. Fatahzadeh M. Inflammatory bowel disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: e1-10 [PMID: 19836703 DOI: 1016/j.tripleo.2009.07.035]
3. Thrash B, Patel M, Shah KR, Boland CR, Menter A. Cutaneous manifestations of gastrointestinal disease: part II. J Am Acad Dermatol 2013; 68: 211.e1-33 quiz 244-246 [PMID: 23317981 DOI: 10.1016/j.jaad.2012.10.036]
4. Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs 2012; 72: 2333-2349 [PMID: 23181971 DOI: 10.165/11638120-000000000-00000]
5. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380: 1590-1605 [PMID: 22914295 DOI: 10.016/S0140-6736(12)60026-9]
6. William T, Marsch WC, Schmidt F, Kreft B. Early oral presentation of Crohn's disease. J Dtsch Dermatol Ges 2007; 5: 678-679 [PMID: 17659041 DOI: 10.1111/j.1610-0387.2007.06429.x]
7. Harikishan G, Reddy NR, Prasad H, Anitha S. Oral Crohn's disease without intestinal manifestations. J Pharm Bioallied Sci 2012; 4: S431-S434 [PMID: 23066305 DOI: 10.4103/0975-7406.1 00322]
8. Boirivant M, Cossu A. Inflammatory bowel disease. Oral Dis 2012; 18: 1-15 [PMID: 21564424 DOI: 10.1111/j.1601-0825.2011.01811.x]
9. Lankarani KB, Karbasi A, Kalantari T, Yarmohammadi H, Saberi-Firoozi M, Alizadeh-Naeeni M, Taghavi AR, Fattahi MR, Ghaderi A. Analysis of cytotoxic T lymphocyte associated antigen 4 gene polymorphisms in patients with ulcerative colitis. J Gastroenterol Hepatol 2006; 21: 449-453 [PMID: 16509873 DOI: 10.1111/j.1440-1746.2005.03956.x]
10. Tamizifar B, Lankarani KB, Naeimi S, Rismankar Zadeh M, Taghavi A, Ghaderi A. Promoter polymorphism of transforming growth factor-beta1 gene and ulcerative colitis. World J Gastroenterol 2008; 14: 243-247 [PMID: 18186562 DOI: 10.3748/wjg.14.243]
11. Yu CG, Huang Q. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease. J Dig Dis 2013; 14: 513-517 [PMID: 23848393 DOI: 10.1111/751-2980.12087]
12. Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev 2014; 13: 3-10 [PMID: 23774107 DOI: 10.1016/j.autrev.2013.06.004]
13. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005; 20: 1691-1695 [PMID: 16246187 DOI: 10.1111/j.1440-1746.2005.03905.x]
14. Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol 2013; 5: 237-247 [PMID: 23922506 DOI: 10.2147/CLEP. S33961]
15. Ko JK, Auyeung KK. Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy. Curr Pharm Des 2013; Epub ahead of print [PMID: 23782147]
16. Frolkis A, Dieleman LA, Barkema H, Panaccione R, Ghosh S, Fedorak RN, Madsen K, Kaplan GG. Environment and the inflammatory bowel diseases. Can J Gastroenterol 2013; 27: e18-e24 [PMID: 23516681]
17. Abdullah M, Syam AF, Simadibrata M, Gunawan J, Makmun D, Rani AA. New insights on the pathomechanisms of inflammatory bowel disease. J Dig Dis 2013; 14: 455-462 [PMID: 23764259 DOI: 10.1111/751-2980.12081]
18. Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2008; 10: 597-605 [PMID: 19006617 DOI: 10.1007/ s11894-008-0108-6]
19. Patil SA, Cross RK. Update in the management of extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2013; 15: 314 [PMID: 23371321 DOI: 10.1007/ s11894-013-0314-8]
20. Armond MC, Carlos RG, Pazzini CA, Pereira LJ, Marques LS. Crohn's disease: clinical manifestations of orthodontic interest. Am J Orthod Dentofacial Orthop 2011; 139: 704-707 [PMID: 21536215 DOI: 10.1016/j.ajodo.2009.05.026]
21. Zbar AP, Ben-Horin S, Beer-Gabel M, Eliakim R. Oral Crohn' s disease: is it a separable disease from orofacial granulomatosis? A review. J Crohns Colitis 2012; 6: 135-142 [PMID: 22325167 DOI: 10.1016/j.crohns.2011.07.001]
22. Barrie A, Regueiro M. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 1424-1429 [PMID: 17567879 DOI: 10.1002/ibd.20196]
23. Trost LB, McDonnell JK. Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 2005; 81: 580-585 [PMID: 16143688 DOI: 10.1136/pgmj.2004.031633]
24. Ardizzone S, Puttini PS, Cassinotti A, Porro GB. Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 2008; 40 (Suppl 2): S253-S259 [PMID: 18598997 DOI: 10.1016/S1590-8658(08)60534-4]
25. Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 2011; 17: 2702-2707 [PMID: 21734777 DOI: 10.3748/wjg.v17.i22.2702]
26. Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011; 7: 235-241 [PMID: 21857821]
27. Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol 2012; 3: 13 [PMID: 22347192 DOI: 10.3389/fphys.2012.00013]
28. Dorofeyev AE, Vasilenko IV, Rassokhina OA. Joint extraintestinal manifestations in ulcerative colitis. Dig Dis 2009; 27: 502-510 [PMID: 19897966 DOI: 10.1159/000233289]
29. Fatahzadeh M, Schwartz RA, Kapila R, Rochford C. Orofacial Crohn's disease: an oral enigma. Acta Dermatovenerol Croat 2009; 17: 289-300 [PMID: 20021984]
30. Nagpal S, Acharya AB, Thakur SL. Periodontal disease and anemias associated with Crohn's disease. A case report. N Y State Dent J 2012; 78: 47-50 [PMID: 22685916]
31. Dudeney TP. Crohn's disease of the mouth. Proc R Soc Med 1969; 62: 1237 [PMID: 5363108]
32. Litsas G. Crohn's disease of the mouth: report of a case. Eur J Paediatr Dent 2011; 12: 198-200 [PMID: 22077691]
33. Pittock S, Drumm B, Fleming P, McDermott M, Imrie C, Flint S, Bourke B. The oral cavity in Crohn's disease. J Pediatr 2001; 138: 767-771 [PMID: 11343060 DOI: 10.1067/mpd.2001.113008]
34. Rowland M, Fleming P, Bourke B. Looking in the mouth for Crohn's disease. Inflamm Bowel Dis 2010; 16: 332-337 [PMID: 19705418 DOI: 10.1002/ibd.20983]
35. Michailidou E, Arvanitidou S, Lombardi T, Kolokotronis A, Antoniades D, Samson J. Oral lesions leading to the diagnosis of Crohn disease: report on 5 patients. Quintessence Int 2009; 40: 581-588 [PMID: 19626233]
36. Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, Ozden A, Duman M. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 2006; 26: 663-668 [PMID: 16136311 DOI: 10.1007/s00296-005-0044-9]
37. Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol 1991; 13: 29-37 [PMID: 2007740 DOI: 10.1097/00004836-199102000-000 08]
38. Ayangco L, Rogers RS, Sheridan PJ. Pyostomatitis vegetans as an early sign of reactivation of Crohn's disease: a case report. J Periodontol 2002; 73: 1512-1516 [PMID: 12546102 DOI: 10.1902/jop.2002.73.12.1512]
39. Alawi F. Granulomatous diseases of the oral tissues: differential diagnosis and update. Dent Clin North Am 2005; 49: 203-221 [PMID: 15567369]
40. Gibson J, Wray D, Bagg J. Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 171-176 [PMID: 10673652 DOI: 10.1067/moe.2000.101810]
41. Basu MK. Oral manifestations of Crohn's disease: studies in the pathogenesis. Proc R Soc Med 1976; 69: 765-766 [PMID: 792883 DOI: 10.1136/gut.16.4.249]
42. Harty S, Fleming P, Rowland M, Crushell E, McDermott M, Drumm B, Bourke B. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol 2005; 3: 886-891 [PMID: 16234026 DOI: 10.1016/S15423565(05)00424-6]
43. Aase S, Koppang HS, Solheim T, Kjaerheim A, Axéll T, Storhaug K, Refsum S. Crohn disease of the oral cavity, illustrated by some cases. Tidsskr Nor Laegeforen 2001; 121: 2489-2491 [PMID: 11875926]
44. Logan RM. Links between oral and gastrointestinal health. Curr Opin Support Palliat Care 2010; 4: 31-35 [PMID: 19952929 DOI: 10.1097/SPC.0b013e32833575e4]
45. Hussey S, Fleming P, Rowland M, Harty S, Chan L, Broderick A, Drumm B, Bourke B. Disease outcome for children who present with oral manifestations of Crohn's disease. Eur Arch Paediatr Dent 2011; 12: 167-169 [PMID: 21640063 DOI: 10.1007/BF03262800]
46. Biancone L, Geboes K, Spagnoli LG, Del Vecchio Blanco G, Monteleone I, Vavassori P, Palmieri G, Chimenti S, Pallone F. Metastatic Crohn's disease of the forehead. Inflamm Bowel Dis 2002; 8: 101-105 [PMID: 11854608 DOI: 10.1097/00054725-200 203000-00006]
47. Lisciandrano D, Ranzi T, Carrassi A, Sardella A, Campanini MC, Velio P, Bianchi PA. Prevalence of oral lesions in inflammatory bowel disease. Am J Gastroenterol 1996; 91: 7-10 [PMID: 8561147]
48. Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100: 350-358 [PMID: 1985033]
49. Ghandour K, Issa M. Oral Crohn's disease with late intestinal manifestations. Oral Surg Oral Med Oral Pathol 1991; 72: 565-567 [PMID: 1745516 DOI: 10.1016/0030-4220(91)90495-X]
50. Stricker T, Braegger CP. Images in clinical medicine. Oral manifestations of Crohn's disease. N Engl J Med 2000; 342: 1644 [PMID: 10833210 DOI: 10.1056/NEJM200006013422205]
51. Ruocco E, Cuomo A, Salerno R, Ruocco V, Romano M, Baroni A. Crohn's disease and its mucocutaneous involvement. Skinmed 2007; 6: 179-185 [PMID: 17618178 DOI: 10.1111/ j.1540-9740.2007.05907.x]
52. Halme L, Meurman JH, Laine P, von Smitten K, Syrjänen S, Lindqvist C, Strand-Pettinen I. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol 1993; 76: 175-181 [PMID: 8361727 DOI: 10.1016/0030-4 220(93)90200-N]
53. Williams AJ, Wray D, Ferguson A. The clinical entity of orofacial Crohn's disease. Q J Med 1991; 79: 451-458 [PMID: 1924680]
54. Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis 2003; 9: 34-40 [PMID: 12617256 DOI: 10.1034/ j.1601-0825.2003.00879.x]
55. Mignogna MD, Fedele S, Lo Russo L, Adamo D, Satriano RA. Effectiveness of small-volume, intralesional, delayedrelease triamcinolone injections in orofacial granulomatosis: a pilot study. J Am Acad Dermatol 2004; 51: 265-268 [PMID: 15280846 DOI: 10.1016/S0190-9622(03)00769-2]
56. Casson DH, Eltumi M, Tomlin S, Walker-Smith JA, Murch SH. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut 2000; 47: 436-440 [PMID: 10940284 DOI: 10.1136/gut.47.3.436]
57. Chavan M, Jain H, Diwan N, Khedkar S, Shete A, Durkar S. Recurrent aphthous stomatitis: a review. J Oral Pathol Med 2012; 41: 577-583 [PMID: 22413800 DOI: 10.1111/j.6000714.2012.01134.x]
58. Landová H, Daněk Z, Gajdziok J, Vetchý D, Stembírek J. Oral mucosa and therapy of recurrent aphthous stomatitis. Ceska Slov Farm 2013; 62: 12-18 [PMID: 23578262]
59. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year followup study. World J Gastroenterol 2003; 9: 2300-2307 [PMID: 14562397]
60. Taş DA, Yakar T, Sakalli H, Serin E. Impact of Helicobacter pylori on the clinical course of recurrent aphthous stomatitis. J Oral Pathol Med 2013; 42: 89-94 [PMID: 22827585 DOI: 10.1111/j.600-0714.2012.01197.x]
61. Kaneko F, Togashi A, Saito S, Sakuma H, Oyama N, Nakamura K, Yokota K, Oguma K. Behçet's disease (Adamantiades-Behçet's disease). Clin Dev Immunol 2011; 2011: 681956 [PMID: 21052488 DOI: 10.1155/2011/681956]
62. Altiner A, Mandal R. Behçet syndrome. Dermatol Online J 2010; 16: 18 [PMID: 21163169]
63. Yaşar S, Yaşar B, Abut E, Aşiran Serdar Z. Clinical importance of celiac disease in patients with recurrent aphthous stomatitis. Turk J Gastroenterol 2012; 23: 14-18 [PMID: 22505374]
64. Rashid M, Zarkadas M, Anca A, Limeback H. Oral manifestations of celiac disease: a clinical guide for dentists. J Can Dent Assoc 2011; 77: b39 [PMID: 21507289]
65. Ferraz EG, Campos Ede J, Sarmento VA, Silva LR. The oral manifestations of celiac disease: information for the pediatric dentist. Pediatr Dent 2012; 34: 485-488 [PMID: 23265166]
66. Kuteyi T, Okwundu CI. Topical treatments for HIV-related oral ulcers. Cochrane Database Syst Rev 2012; 1: CD007975 [PMID: 22258979 DOI: 10.1002/14651858.CD007975.pub2]
67. Liu C, Zhou Z, Liu G, Wang Q, Chen J, Wang L, Zhou Y, Dong G, Xu X, Wang Y, Guo Y, Lin M, Wu L, Du G, Wei C, Zeng X, Wang X, Wu J, Li B, Zhou G, Zhou H. Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration. Am J Med 2012; 125: 292-301 [PMID: 22340928 DOI: 10.1016/j.amjmed.2011.09.011]
68. Descroix V, Coudert AE, Vigé A, Durand JP, Toupenay S, Molla M, Pompignoli M, Missika P, Allaert FA. Efficacy of topical 1% lidocaine in the symptomatic treatment of pain associated with oral mucosal trauma or minor oral aphthous ulcer: a randomized, double-blind, placebo-controlled, parallel-group, single-dose study. J Orofac Pain 2011; 25: 327-332 [PMID: 22247928]
69. Keenan AV. Promising results for dexamethasome ointment for treatment of recurrent aphthae. Evid Based Dent 2012; 13: 75 [PMID: 23059918 DOI: 10.1038/sj.ebd.6400872]
70. McBride DR. Management of aphthous ulcers. Am Fam Physician 2000; 62: 149-154+160 [PMID: 10905785]
71. Malins TJ, Wilson A, Ward-Booth RP. Recurrent buccal space abscesses: a complication of Crohn's disease. Oral Surg Oral Med Oral Pathol 1991; 72: 19-21 [PMID: 1891238 DOI: 10.1016/0030-4220(91)90182-C]
72. Eloubeidi MA, Onken JE. Manifestations of Crohn's disease. Dig Dis 1998; 16: 262 [PMID: 9750061 DOI: 10.1159/000016874]
73. Ottaviani F, Schindler A, Capaccio P, Petrone M, Bianchi Porro G. New therapy for orolaryngeal manifestations of Crohn' s disease. Ann Otol Rhinol Laryngol 2003; 112: 37-39 [PMID: 12537056]
74. Daley TD, Armstrong JE. Oral manifestations of gastrointestinal diseases. Can J Gastroenterol 2007; 21: 241-244 [PMID: 17431513]
75. Endo H, Rees TD. Cinnamon products as a possible etiologic factor in orofacial granulomatosis. Med Oral Patol Oral Cir Bucal 2007; 12: E440-E444 [PMID: 17909510]
76. White A, Nunes C, Escudier M, Lomer MC, Barnard K, Shirlaw P, Challacombe SJ, Sanderson JD. Improvement in orofacial granulomatosis on a cinnamonand benzoate-free diet. Inflamm Bowel Dis 2006; 12: 508-514 [PMID: 16775496 DOI: 10.1097/00054725-200606000-00011]
77. Mijandrusić-Sincić B, Licul V, Gorup L, Brncić N, Glazar I, Lucin K. Pyostomatitis vegetans associated with inflammatory bowel disease--report of two cases. Coll Antropol 2010; 34(Suppl 2): 279-282 [PMID: 21305742]
78. Femiano F, Lanza A, Buonaiuto C, Perillo L, Dell'Ermo A, Cirillo N. Pyostomatitis vegetans: a review of the literature. Med Oral Patol Oral Cir Bucal 2009; 14: E114-E117 [PMID: 19242389]
79. Markiewicz M, Suresh L, Margarone J, Aguirre A, Brass C. Pyostomatitis vegetans: A clinical marker of silent ulcerative colitis. J Oral Maxillofac Surg 2007; 65: 346-348 [PMID: 17236948 DOI: 10.1016/j.joms.2005.07.020]
80. Ojha J, Cohen DM, Islam NM, Stewart CM, Katz J, Bhattacharyya I. Gingival involvement in Crohn disease. J Am Dent Assoc 2007; 138: 1574-1581 quiz 1614-1615 [PMID: 18056101]
81. Ruiz-Roca JA, Berini-Aytés L, Gay-Escoda C. Pyostomatitis vegetans. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 447-454 [PMID: 15772593 DOI: 10.1016/j.tripleo.2003.08.022]
82. Hegarty AM, Barrett AW, Scully C. Pyostomatitis vegetans. Clin Exp Dermatol 2004; 29: 1-7 [PMID: 14723710 DOI: 10.1111/j.1365-2230.2004.01438.x]
83. Philpot HC, Elewski BE, Banwell JG, Gramlich T. Pyostomatitis vegetans and primary sclerosing cholangitis: markers of inflammatory bowel disease. Gastroenterology 1992; 103: 668-674 [PMID: 1634082]
84. Lopez-Jornet P, Gomez-Garcia F, Camacho-Alonso F. Pyostomatitis vegetans. Clinical marker of ulcerative colitis. N Y State Dent J 2012; 78: 36-37 [PMID: 22685913]
85. Shah S, Cotliar J. Images in clinical medicine. Pyostomatitis vegetans. N Engl J Med 2013; 368: 1918 [PMID: 23675660 DOI: 10.056/NEJMicm1211738]
86. Nico MM, Hussein TP, Aoki V, Lourenço SV. Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus. J Oral Pathol Med 2012; 41: 584-588 [PMID: 22563766 DOI: 10.1111/j.600-0714.2012.01152.x]
87. Matias Fde A, Rosa DJ, Carvalho MT, Castañon MC. Pyodermatitis-pyostomatitis vegetans: case report and review of medical literature. An Bras Dermatol 2011; 86: S137-S140 [PMID: 22068794 DOI: 10.1590/S0365-05962011000700036]
88. Nigen S, Poulin Y, Rochette L, Lévesque MH, Gagné E. Pyodermatitis-pyostomatitis vegetans: two cases and a review of the literature. J Cutan Med Surg 2003; 7: 250-255 [PMID: 12574902 DOI: 10.1007/s10227-002-0112-7]
89. Brinkmeier T, Frosch PJ. Pyodermatitis-pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low-dose prednisolone. Acta Derm Venereol 2001; 81: 134-136 [PMID: 11501652 DOI: 10.1080/0001555015238429 0]
90. Calobrisi SD, Mutasim DF, McDonald JS. Pyostomatitis vegetans associated with ulcerative colitis. Temporary clearance with fluocinonide gel and complete remission after colectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 452-454 [PMID: 7614204 DOI: 10.1016/S10792104(05)80126-X]
91. Stewart CM, Watson RE. Experimental oral foreign body reactions. Commonly employed dental materials. Oral Surg Oral Med Oral Pathol 1990; 69: 713-719 [PMID: 2192333 DOI: 10.1016/0030-4220(90)90354-U]
92. Mignogna MD, Muzio LL, Favia G, Ruoppo E, Sammartino G, Zarrelli C, Bucci E. Oral tuberculosis: a clinical evaluation of 42 cases. Oral Dis 2000; 6: 25-30 [PMID: 10673784 DOI: 10.1111/j.1601-0825.2000.tb00317.x]
93. Bouaziz A, Le Scanff J, Chapelon-Abric C, Varron L, Khenifer S, Gleizal A, Bentz MH, Barthel A, Valeyre D, Seve P. Oral involvement in sarcoidosis: report of 12 cases. QJM 2012; 105: 755-767 [PMID: 22422021 DOI: 10.1093/qjmed/hcs042]
94. Boh EE, Al-Smadi RM. Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin 2002; 20: 533-546 [PMID: 12170886 DOI: 10.1016/S0733-8635(02)00014-1]
95. Timani S, Mutasim DF. Skin manifestations of inflammatory bowel disease. Clin Dermatol 2008; 26: 265-273 [PMID: 18640523 DOI: 10.1016/j.clindermatol.2007.10.018]
96. Pironi L, Cornia GL, Ursitti MA, Dallasta MA, Miniero R, Fasano F, Miglioli M, Barbara L. Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine. Int J Clin Pharmacol Res 1988; 8: 143-148 [PMID: 2897953]
97. Oliva MM, Lake AM. Nutritional considerations and management of the child with inflammatory bowel disease. Nutrition 1996; 12: 151-158 [PMID: 8798217 DOI: 10.1016/ S0899-9007(96)91118-1]
98. Waśko-Czopnik D, Paradowski L. The influence of deficiencies of essential trace elements and vitamins on the course of Crohn's disease. Adv Clin Exp Med 2012; 21: 5-11 [PMID: 23214293]
99. Benjamin J, Makharia GK, Kalaivani M, Joshi YK. Nutritional status of patients with Crohn's disease. Indian J Gastroenterol 2008; 27: 195-200 [PMID: 19112190]
100. Baccaglini L, Lalla RV, Bruce AJ, Sartori-Valinotti JC, Latortue MC, Carrozzo M, Rogers RS. Urban legends: recurrent aphthous stomatitis. Oral Dis 2011; 17: 755-770 [PMID: 21812866 DOI: 10.1111/j.601-0825.2011.01840.x]
101. Chiang CK, Chou YH, Chen YH, Sha CB, Liang CS. Aphthous ulcers associated with bupropion in a female adolescent: a case verified by rechallenge. Gen Hosp Psychiatry 2011; 33: 411.e1-411.e2 [PMID: 21762840 DOI: 10.1016/j.genhospps ych.2011.01.010]
102. Eggerath J, English H, Leichter JW. Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment. J N Z Soc Periodontol 2005; (88): 7-14 [PMID: 16237888]
103. Aldemir NM, Begenik H, Emre H, Erdur FM, Soyoral Y. Amlodipine-induced gingival hyperplasia in chronic renal failure: a case report. Afr Health Sci 2012; 12: 576-578 [PMID: 23516009]
104. Mohan RP, Rastogi K, Bhushan R, Verma S. Phenytoin-induced gingival enlargement: a dental awakening for patients with epilepsy. BMJ Case Rep 2013; 2013: pii: bcr2013008679 [PMID: 23616318 DOI: 10.1136/bcr-2013-008679]
105. Girlich C, Bogenrieder T, Palitzsch KD, Schölmerich J, Lock G. Orofacial granulomatosis as initial manifestation of Crohn's disease: a report of two cases. Eur J Gastroenterol Hepatol 2002; 14: 873-876 [PMID: 12172408 DOI: 10.1097/00042737-2002080 00-00010]
106. Patel P, Brostoff J, Campbell H, Goel RM, Taylor K, Ray S, Lomer M, Escudier M, Challacombe S, Spencer J, Sanderson J. Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clin Transl Allergy 2013; 3: 26 [PMID: 23947721 DOI: 10.1186/2045-7022-3-26]
107. Tavarela Veloso F. Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20(Suppl 4): 50-53 [PMID: 15352894 DOI: 10.1111/ j.1365-2036.2004.02055.x]